-+ 0.00%
-+ 0.00%
-+ 0.00%

BioMarin appoints Bristol Myers Squibb research chief Robert Plenge to board

PUBT·09/14/2026 13:06:51
Listen to the news
BioMarin appoints Bristol Myers Squibb research chief Robert Plenge to board
  • BioMarin appointed Bristol Myers Squibb Chief Research Officer Robert Plenge to its board, effective Sept. 10, 2026.
  • Plenge is an executive vice president at Bristol Myers Squibb, leading research across nine sites worldwide.
  • He joined Bristol Myers Squibb in 2019 via its Celgene acquisition, where he led immunology and inflammation research.
  • Earlier roles included head of translational medicine at Merck, assistant professor at Harvard Medical School, and associate member at the Broad Institute.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMarin Pharmaceutical Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609140905PR_NEWS_USPR_____SF46579) on September 14, 2026, and is solely responsible for the information contained therein.